Utilising Pancreatic Exocrine Insufficiency in the Detection of Resectable Pancreatic Ductal Adenocarcinoma
Declan McDonnell, Paul R Afolabi, Sam Wilding, Gareth O Griffiths, Jonathan R Swann, Christopher D Byrne, Zaed Z Hamady, Hideya Yamazaki · 2023
Read Utilising Pancreatic Exocrine Insufficiency in the Detection of Resectable Pancreatic Ductal Adenocarcinoma by Declan McDonnell, Paul R Afolabi, Sam Wilding, Gareth O Griffiths, Jonathan R Swann, Christopher D Byrne, Zaed Z Hamady, Hideya Yamazaki (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10741412.txt.
Description
Declan McDonnell and co-authors present a 2023 study of two tests for a weak pancreas as a clue to early pancreatic cancer. This cancer is most often found late, which drives its high death rate. Early finding opens better care options, so cheap early clues are prized.
The weak pancreas state, where the organ makes too few digestive juices, can be checked by a breath test and a stool test. The team ran both tests on patients with removable cancer, healthy adults, and patients with long term pancreas swelling. Both tests split the cancer group from the healthy group with fair strength. Scores matched those seen in the swelling group. The authors call for large trials in high risk groups.
Catalog record
| CREATOR | Declan McDonnell, Paul R Afolabi, Sam Wilding, Gareth O Griffiths, Jonathan R Swann, Christopher D Byrne, Zaed Z Hamady, Hideya Yamazaki |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 33 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |